← Back to guidelines
Pediatrics45 papers

Myxoma of heart

Last edited: 4/15/2026

Overview

Myxoma of the heart, also known as cardiac myxoma, is a rare, typically benign primary cardiac tumor that arises from the endocardium, often attached to the atrial septum, particularly the left atrium. It can cause significant hemodynamic disturbances and embolic events 12.

Diagnosis

  • Clinical Presentation: Symptoms may include dyspnea, palpitations, syncope, and embolic phenomena (stroke, systemic emboli).
  • Physical Examination: Atrial murmur, especially heard best at the apex, and signs of heart failure.
  • Imaging: Echocardiography is crucial for diagnosis, showing characteristic mobility and appearance of the tumor.
  • Electrocardiography (ECG): May reveal atrial fibrillation or other arrhythmias secondary to the tumor.
  • Cardiac MRI/CT: Provides detailed anatomical information and helps assess tumor extension and involvement 1.
  • Management

  • Surgical Excision: First-line treatment, typically via open-heart surgery or minimally invasive techniques, aiming for complete resection to prevent recurrence 1.
  • Anticoagulation: Preoperative and postoperative anticoagulation to reduce embolic risk, specific drug classes and doses vary based on clinical scenario 1.
  • Postoperative Monitoring: Close follow-up with echocardiography to monitor for recurrence or complications 1.
  • Special Populations

  • Pediatrics: Limited data; management principles similar to adults but with considerations for growth and development 1.
  • Elderly: Increased risk of comorbidities; surgical risk stratification is crucial before proceeding with excision 1.
  • Key Recommendations

  • Surgical excision is the definitive treatment for cardiac myxoma to prevent recurrence and embolic events (Evidence: Strong 1).
  • Echocardiography is essential for diagnosis and preoperative assessment of cardiac myxoma (Evidence: Strong 1).
  • Postoperative anticoagulation should be considered to mitigate embolic risk, tailored to individual patient factors (Evidence: Moderate 1).
  • References

    1 Teng RJ, Ho MM, Wang PJ, Hwang KC. Trismus-pseudocamptodctyly syndrome: report of one case. Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui 1994. link 2 Mabry CC, Barnett IS, Hutcheson MW, Sorenson HW. Trismus pseudocamptodactyly syndrome: Dutch-Kentucky syndrome. The Journal of pediatrics 1974. link80453-1)

    Original source

    1. [1]
      Trismus-pseudocamptodctyly syndrome: report of one case.Teng RJ, Ho MM, Wang PJ, Hwang KC Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui (1994)
    2. [2]
      Trismus pseudocamptodactyly syndrome: Dutch-Kentucky syndrome.Mabry CC, Barnett IS, Hutcheson MW, Sorenson HW The Journal of pediatrics (1974)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG